Literature DB >> 1377922

Effects of vasoactive neuropeptides on human saphenous vein.

T N Luu1, A H Chester, G S O'Neil, S Tadjkarimi, M H Yacoub.   

Abstract

OBJECTIVE: To assess the role of neuropeptides in the control of vascular tone in the human saphenous vein the actions of substance P, vasoactive intestinal peptide, calcitonin gene related peptide, neuropeptide Y, and somatostatin on this blood vessel were examined.
METHODS: In vitro organ bath techniques were used with preparations of saphenous veins obtained from 29 patients (aged 41-66) who were undergoing coronary bypass surgery.
RESULTS: Substance P, vasoactive intestinal peptide, and calcitonin gene related peptide relaxed pre-constricted vessels in a dose dependent manner with a rapid onset of action, taking one to two minutes to reach a plateau at each dose. Substance P (10(-9) to 10(-6) mol/l) induced relaxation with a maximum response (mean (SEM)) 23.0 (6.6)% of the total relaxation induced by glyceryl trinitrate 1 microgram/ml and a 50% maximal effective concentration of 6.8 x 10(-9) mol/l. Vasoactive intestinal peptide (10(-10) to 10(-7) mol/l) produced a relaxation of 27.0 (5.1)% at 10(-7) mol/l. The maximum responses induced by substance P and vasoactive intestinal peptide were significantly reduced, to 3.7 (2.8)% and 4.7 (2.0)% respectively, after removal of the endothelium. Calcitonin gene related peptide (10(-10) to 10(-7) mol/l) elicited only 14.3 (2.6)% relaxation at 10(-7) mol/l, and this was not affected by removal of the endothelium. By contrast, neuropeptide Y and somatostatin exerted concentration dependent constriction on resting vessels. Neuropeptide Y (10(-10) to 10(-7) mol/l) caused prolonged contraction (roughly 20 minutes to reach a maximum plateau at each dose). At 10(-7) mol/l, the constriction amounted to 28.0 (12.0)% of the response to 90 mM KCl, in ring segments with or without endothelium. Somatostatin (10(-10) to 10(-6) mol/l) quickly caused contraction with a maximum response of 42.7 (15.0)% and a maximum response of 42.7 (15.0)% and a 50% maximal effective concentration of 6.7 x 10(-6) mol/l. The constriction was greatly increased when endothelium was removed, with a maximum response of 78.2 (16.8)% and a 50% maximal effective concentration of 4.3 x 10(-7) mol/l.
CONCLUSIONS: Vasoactive peptides have diverse effects on the vascular tone these effects are endothelium dependent. The exact physiological role and implication for performance of bypass grafts require further investigation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377922      PMCID: PMC1024890          DOI: 10.1136/hrt.67.6.474

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  34 in total

1.  Calcitonin gene-related peptide (CGRP) is a potent non-endothelium-dependent inhibitor of coronary vasomotor tone.

Authors:  B Greenberg; K Rhoden; P Barnes
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

Review 2.  Endothelial modulation of coronary tone.

Authors:  E Bassenge; R Busse
Journal:  Prog Cardiovasc Dis       Date:  1988 Mar-Apr       Impact factor: 8.194

3.  Vasoactive intestinal peptide evokes endothelium-dependent relaxation and cyclic AMP accumulation in rat aorta.

Authors:  T Sata; J Linden; L W Liu; E Kubota; S I Said
Journal:  Peptides       Date:  1988 Jul-Aug       Impact factor: 3.750

4.  Spasm of the aortocoronary venous graft.

Authors:  V J D'Souza; G Velasquez; F R Kahl; B T Hackshaw; K Amplatz
Journal:  Radiology       Date:  1984-04       Impact factor: 11.105

5.  Measurement of fasting and postprandial plasma VIP in man.

Authors:  S J Mitchell; S R Bloom
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

6.  Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man.

Authors:  J M Lundberg; J Fahrenkrug; T Hökfelt; C R Martling; O Larsson; K Tatemoto; A Anggård
Journal:  Peptides       Date:  1984 May-Jun       Impact factor: 3.750

7.  Vasoactive intestinal polypeptide relaxes pulmonary artery by an endothelium-independent mechanism.

Authors:  T Sata; H P Misra; E Kubota; S I Said
Journal:  Peptides       Date:  1986       Impact factor: 3.750

8.  Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action.

Authors:  C Wahlestedt; L Edvinsson; E Ekblad; R Håkanson
Journal:  J Pharmacol Exp Ther       Date:  1985-09       Impact factor: 4.030

9.  Calcitonin gene-related peptide: a potent dilator of human epicardial coronary arteries.

Authors:  J McEwan; S Larkin; G Davies; S Chierchia; M Brown; J Stevenson; I MacIntyre; A Maseri
Journal:  Circulation       Date:  1986-12       Impact factor: 29.690

10.  Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels.

Authors:  L Edvinsson; E Ekblad; R Håkanson; C Wahlestedt
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

View more
  3 in total

1.  Altered post-capillary and collecting venular reactivity in skeletal muscle with metabolic syndrome.

Authors:  Kent A Lemaster; Zahra Farid; Robert W Brock; Carl D Shrader; Daniel Goldman; Dwayne N Jackson; Jefferson C Frisbee
Journal:  J Physiol       Date:  2017-07-05       Impact factor: 5.182

Review 2.  The role of endothelin-1 in pulmonary arterial hypertension.

Authors:  Adrian H Chester; Magdi H Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2014-06-18

Review 3.  The cardiovascular system and the biochemistry of grafts used in heart surgery.

Authors:  Suna Aydin; Suleyman Aydin; Mehmet Nesimi Eren; Ibrahim Sahin; Musa Yilmaz; Mehmet Kalayci; Orhan Gungor
Journal:  Springerplus       Date:  2013-11-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.